- Home
- VEEE vs KLTO Comparison
VEEE vs KLTO Comparison
Compare VEEE & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- KLTO
- Stock Information
- Founded
- VEEE 1994
- KLTO 2019
- Country
- VEEE United States
- KLTO United States
- Employees
- VEEE N/A
- KLTO N/A
- Industry
- VEEE Marine Transportation
- KLTO
- Sector
- VEEE Industrials
- KLTO
- Exchange
- VEEE Nasdaq
- KLTO NYSE
- Market Cap
- VEEE 6.4M
- KLTO 7.1M
- IPO Year
- VEEE 2021
- KLTO N/A
- Fundamental
- Price
- VEEE $2.46
- KLTO $0.21
- Analyst Decision
- VEEE
- KLTO
- Analyst Count
- VEEE 0
- KLTO 0
- Target Price
- VEEE N/A
- KLTO N/A
- AVG Volume (30 Days)
- VEEE 1.1M
- KLTO 35.4M
- Earning Date
- VEEE 05-08-2025
- KLTO 05-15-2025
- Dividend Yield
- VEEE N/A
- KLTO N/A
- EPS Growth
- VEEE N/A
- KLTO N/A
- EPS
- VEEE N/A
- KLTO N/A
- Revenue
- VEEE $12,724,465.00
- KLTO N/A
- Revenue This Year
- VEEE N/A
- KLTO N/A
- Revenue Next Year
- VEEE N/A
- KLTO N/A
- P/E Ratio
- VEEE N/A
- KLTO N/A
- Revenue Growth
- VEEE N/A
- KLTO N/A
- 52 Week Low
- VEEE $2.05
- KLTO $0.11
- 52 Week High
- VEEE $9.30
- KLTO $0.99
- Technical
- Relative Strength Index (RSI)
- VEEE 48.05
- KLTO N/A
- Support Level
- VEEE $2.13
- KLTO N/A
- Resistance Level
- VEEE $2.35
- KLTO N/A
- Average True Range (ATR)
- VEEE 0.17
- KLTO 0.00
- MACD
- VEEE 0.00
- KLTO 0.00
- Stochastic Oscillator
- VEEE 44.59
- KLTO 0.00
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.